Leland Gershell
2012 - Tonix Pharmaceuticals Holding
In 2012, Leland Gershell earned a total compensation of $726.2K as Chief Financial Officer at Tonix Pharmaceuticals Holding.
Compensation breakdown
| Option Awards | $587,654 |
|---|---|
| Salary | $138,542 |
| Total | $726,196 |
Gershell received $587.7K in option awards, accounting for 81% of the total pay in 2012.
Gershell also received $138.5K in salary.
Rankings
In 2012, Leland Gershell's compensation ranked 7,410th out of 11,487 executives tracked by ExecPay. In other words, Gershell earned more than 35.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,410 out of 11,487 | 36th |
Division Manufacturing | 2,660 out of 4,253 | 38th |
Major group Chemicals And Allied Products | 687 out of 1,198 | 43rd |
Industry group Drugs | 478 out of 920 | 48th |
Industry Pharmaceutical Preparations | 377 out of 700 | 46th |
Source: SEC filing on May 2, 2014.
Gershell's colleagues
We found two more compensation records of executives who worked with Leland Gershell at Tonix Pharmaceuticals Holding in 2012.